Lv1
20 积分 2024-04-22 加入
Gemcitabine and cisplatin plus durvalumab with or without tremelimumab in chemotherapy-naive patients with advanced biliary tract cancer: An open-label, single-centre, phase 2 study
8天前
已完结
Efficacy and safety of anlotinib plus anti-PD-1 agents in patients with refractory advanced biliary tract cancers
9天前
已完结
Camrelizumab plus oxaliplatin-based chemotherapy as first-line therapy for advanced biliary tract cancer: A multicenter, phase 2 trial
9天前
已完结
Gemcitabine and cisplatin or oxaliplatin chemotherapy combined with atezolizumab plus bevacizumab for advanced biliary tract cancers: a single-arm trial
9天前
已完结
Atezolizumab: an investigational agent for the treatment of biliary tract cancer
10天前
已完结
Atezolizumab: an investigational agent for the treatment of biliary tract cancer
10天前
已关闭
Immune checkpoint inhibitors and combinations with other agents in cholangiocarcinoma
11天前
已完结
皖公网安备34019202002308
